Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.8590
+0.0027 (0.32%)
At close: Jun 13, 2025, 4:00 PM
0.8400
-0.0190 (-2.21%)
After-hours: Jun 13, 2025, 7:48 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $4.41 million as of June 13, 2025. Its market cap has increased by 19.68% in one year.
Market Cap
4.41M
Enterprise Value
-203.40K
1-Year Change
19.68%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.17M to $4.41M, a decrease of -83.15%. That is a compound annual growth rate of -37.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 4.41M | -21.20% |
| Dec 31, 2024 | 5.60M | 17.66% |
| Dec 29, 2023 | 4.76M | -39.13% |
| Dec 30, 2022 | 7.82M | -59.16% |
| Dec 27, 2021 | 19.14M | -26.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.44B |
| Johnson & Johnson | 376.00B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.78B |
| UnitedHealth Group | 287.41B |
| Abbott Laboratories | 236.43B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |